Beckman Coulter Biomedical GmbH recalls DxA 5000; Catalog Number:B50516; UDI:15099590707118 - Product Usage: The DxA 5000 is a high-speed, modular, automated s…
- Recall date
- June 17, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2983-2020
- FDA classification
- Class II
- Brand / firm
- Beckman Coulter Biomedical GmbH
- Sold / distributed
- Worldwide distribution - US Nationwide distribution including in the states of Illinois, Ohio, Pennsylvania, and West Virginia. The countries of Australia, Canada, China, Czech Republic, France, Israel, Italy, Germany, Switzerland, Spain, Netherlands, and United Kingdom.
Why it was recalled
The DxA 5000 instructions for use may be confusing regarding the re-use of sample IDs. Beckman Coulter has received complaints where the re-use of sample barcodes were not being detected by the system .
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
DxA 5000; Catalog Number:B50516; UDI:15099590707118 - Product Usage: The DxA 5000 is a high-speed, modular, automated sample handling system that performs pre-analytical and post-analytical sample processing and storage. The automation system also sorts, routes, and presents sample tubes to analyzers for analysis. The DxA 5000 also consolidates a variety of analytical instruments, such as an Immunoassay analyzer, into a unified workstation on a track system.
Get recall alerts
Free email alert whenever Beckman Coulter Biomedical GmbH has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Beckman Coulter Biomedical GmbH